Advanced search
Publication Cover
Journal of Hepatocellular Carcinoma Volume 11, 2024 - Issue
Submit an article Journal homepage
35
Views
0
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH

Clinical Characteristics of Non-B and Non-C Biopsy-Proven Primary Liver Cancers in an HBV- Endemic Area: A Retrospective Study

Zhen HuDepartment of Infectious Diseases, The Second Xiangya Hospital, Central South University, Changsha, Hunan, 410011, People’s Republic of ChinaView further author information
&
Huaying ZhouDepartment of Infectious Diseases, The Second Xiangya Hospital, Central South University, Changsha, Hunan, 410011, People’s Republic of ChinaCorrespondence[email protected]
View further author information
Pages 767-774 | Received 31 Jan 2024, Accepted 19 Apr 2024, Published online: 24 Apr 2024

References

  • Rahib L, Smith BD, Alizenberg R, et al. Projecting cancer incidence and deaths to 2030: the unexpected burden of thyroid, liver, and pancreas cancers in the United States. Cancer Res. 2014;74(11):2913–2921. doi:10.1158/0008-5472.CAN-14-0155
  • Ananthakrishnan A, Gogineni V, Saeian K. Epidemiology of primary and secondary liver cancers. Semin Intervent Radiol. 2006;23(1):047–063. doi:10.1055/s-2006-939841
  • de Martel C, Georges D, Bray F, et al. Global burden of cancer attributable to infections in 2018: a worldwide incidence analysis. Lancet Glob Health. 2020;8(2):e180–e190. doi:10.1016/S2214-109X(19)30488-7
  • Sung H, Ferlay J, Siegel RL, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209–249. doi:10.3322/caac.21660
  • Tateishi R, Matsumura T, Okanoue T, et al. Hepatocellular carcinoma development in diabetic patients: a nationwide survey in Japan. J Gastroenterol. 2021;56(3):261–273. doi:10.1007/s00535-020-01754-z
  • Calle EE, Rodriguez C, Walker-Thurmond K, et al. Overweight, obesity, and mortality from cancer in a prospectively studied cohort of US adults. N Engl J Med. 2003;348(17):1625–1638. doi:10.1056/NEJMoa021423
  • El-Serag HB, Tran T, Everhart JE. Diabetes increases the risk of chronic liver disease and hepatocellular carcinoma. Gastroenterology. 2004;126(2):460–468. doi:10.1053/j.gastro.2003.10.065
  • Wang Z, Sheng -Y-Y, Dong Q-Z, et al. Hepatitis B virus and hepatitis C virus play different prognostic roles in intrahepatic cholangiocarcinoma: a meta-analysis. World J Gastroenterol. 2016;22(10):3038–3051. doi:10.3748/wjg.v22.i10.3038
  • Jeong S, Luo G, Wang Z-H, et al. Impact of viral hepatitis B status on outcomes of intrahepatic cholangiocarcinoma: a meta-analysis. Hepatol Int. 2018;12(4):330–338. doi:10.1007/s12072-018-9881-y
  • Tao L-Y, X-d H, Xiu D-R. Hepatitis B virus is associated with the clinical features and survival rate of patients with intrahepatic cholangiocarcinoma. Clin Res Hepatol Gastroenterol. 2016;40(6):682–687. doi:10.1016/j.clinre.2016.04.001
  • Wongjarupong N, Assavapongpaiboon B, Susantitaphong P, et al. Non-alcoholic fatty liver disease as a risk factor for cholangiocarcinoma: a systematic review and meta-analysis. BMC Gastroenterol. 2017;17(1):149.
  • Kim J, Kang W, Sinn DH, et al. Potential etiology, prevalence of cirrhosis, and mode of detection among patients with non-B non-C hepatocellular carcinoma in Korea. Korean J Intern Med. 2020;35(1):65–78. doi:10.3904/kjim.2018.040
  • Abu-Saad K, Murad H, Barid R, et al. Development and efficacy of an electronic, culturally adapted lifestyle counseling tool for improving diabetes-related dietary knowledge: randomized controlled trial among ethnic minority adults with type 2 diabetes mellitus. Med Internet Res. 2019;21(10):e13674. doi:10.2196/13674
  • Kwak HW, Park JW, Koh YH, et al. Clinical characteristics of patients with cryptogenic hepatocellular carcinoma in a hepatitis B virus-endemic area. Liver Cancer. 2016;5(1):21–36. doi:10.1159/000367756
  • Noureddin M, Rinella ME. Nonalcoholic fatty liver disease, diabetes, obesity, and hepatocellular carcinoma. Clin Liver Dis. 2015;19(2):361–379. doi:10.1016/j.cld.2015.01.012
  • Marengo A, Rosso C, Bugianesi E. Liver cancer: connections with obesity fatty liver, and cirrhosis. Annu Rev Med. 2016;67(1):103–117. doi:10.1146/annurev-med-090514-013832
  • Kim HJ, Kim JS, Joo MK, et al. Hepatolithiasis and intrahepatic cholangiocarcinoma: a review. World J Gastroenterol. 2015;21(48):13418–13431. doi:10.3748/wjg.v21.i48.13418
  • Clements O, Eliahoo J, Kim JU, et al. Risk factors for intrahepatic and extrahepatic cholangiocarcinoma: a systematic review and meta-analysis. J Hepatol. 2020;72(1):95–103. doi:10.1016/j.jhep.2019.09.007
  • Jackson SS, Pfeiffer RM, Gabbi C, et al. Menopausal hormone therapy and risk of biliary tract cancers. Hepatology. 2022;75(2):309–321. doi:10.1002/hep.32198
  • Utada M, Ohno Y, Tamaki T, et al. Long-term trends in incidence and mortality of intrahepatic and extrahepatic bile duct cancer in Japan. J Epidemiol. 2014;24(3):193–199. doi:10.2188/jea.JE20130122

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.